Inovio says Zika vaccine shows response in mice

Gene One Life Science

17/02/2016 12:11

Feb 17 (Reuters) - Drug developer Inovio Pharmaceuticals Inc 
 INO.O  said preclinical testing of its vaccine for Zika virus 
induced robust and durable response in mice and that it expected 
to test the vaccine in humans before the end of 2016. 
    Inovio said on Wednesday it was developing the vaccine with 
GeneOne Life Sciences Inc  011000.KS  and academic 
collaborators.  urn:newsml:reuters.com:*:nGNXMMJAGa 
 
     
 
 (Reporting by Amrutha Penumudi in Bengaluru; Editing by Kirti 
Pandey) 
 ((penumudi.amrutha@thomsonreuters.com; within U.S. +1 646 223 
8780 outside U.S. +91 80 6749 4486; Reuters Messaging: 
penumudi.amrutha.thomsonreuters.com@reuters.net)) 
 
Keywords: HEALTH ZIKA/INOVIO PHARMA